52w high/low | ₹275.1 / ₹79.05 |
P/E ratio | 23.65 |
Dividend | 0 |
ROE | 9.31 |
ROCE | 11.12 |
Face value | 10 |
Book value | ₹147.27Cr |
Market capital | ₹521.39Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
Incorporated in May '92 as a public limited company, Kilitch Drugs (India) (KDIL) went public in Feb. '94 to set up a pharmaceutical formulation plant at Thane to manufacture pharmaceutical products in the form of tablets, capsules,liquid orals, ointments, creams and injectables. Even before the plant was commissioned, the company came out with a rights issue in Oct. '95 to expand the injectible capacity. Commercial production at the plant at Thane commenced in 1996. The company has two divisions - O T C and ethical. A Pharmaceutical formulation plant at Sana'a Republic of Yemen was set up at a cost of Rs 15 crore by entering into an agreement with Al-Fath Trading Corporation. It also entered into an agreement with a Miami company for the export of their medicine to West Indies, south and central America.